InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
2
T+90 hit rate
25%
T+90 mean return
-9.8%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Hansen Carl L. G., Chairman & CEO. Officer active across 1 company, notably AbCellera Biologics Inc.. Aggregated, 16 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €220.9m. History available since 9 June 2021. The latest transaction was disclosed on 25 November 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations16 total
56,125 shares@ US$2.700.1% of flowCommon SharesSEC:0001628280-24-049327:0
56,125 shares@ US$2.700.1% of flowCommon SharesSEC:0001628280-24-041217:0
56,125 shares@ US$2.700.1% of flowCommon SharesSEC:0001628280-24-026338:0
56,125 shares@ US$2.700.1% of flowCommon SharesSEC:0001703057-24-000026:0
56,125 shares@ US$2.700.1% of flowCommon SharesSEC:0001703057-23-000044:0
56,125 shares@ US$2.700.1% of flowCommon SharesSEC:0001703057-23-000027:0
56,125 shares@ US$2.700.1% of flowCommon SharesSEC:0001209191-23-032793:0
56,125 shares@ US$2.700.1% of flowCommon SharesSEC:0001209191-23-012199:0
56,125 shares@ US$2.700.1% of flowCommon SharesSEC:0001209191-22-058300:0
56,125 shares@ US$2.700.1% of flowCommon SharesSEC:0001209191-22-046995:0
56,125 shares@ US$2.700.012% mcap0.1% of flowCommon SharesSEC:0001209191-22-030394:0
56,125 shares@ US$2.700.011% mcap0.1% of flowCommon SharesSEC:0001209191-22-013012:0
224,500 shares@ US$15.030.24% mcap1.3% of flowCommon SharesSEC:0001209191-21-066133:0
224,500 shares@ US$15.031.3% of flowCommon SharesSEC:0001209191-21-066133
5,598,420 shares@ US$24.038.84% mcap48.6% of flowCommon SharesSEC:0000899243-21-022993:0
5,598,420 shares@ US$24.0348.3% of flowCommon SharesSEC:0000899243-21-022993
16 of 16 declarations
About Hansen Carl L. G.
Carl L. G. Hansen is the Chief Executive Officer of AbCellera Biologics Inc. He is responsible for the strategic direction of the company and overall management of its operations. His role is essential in ensuring innovation and growth for AbCellera in the biotechnology sector.
